Stifel Financial
ORIC icon

Stifel Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Stifel Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Sell
11,234
-12,665
-53% -$115K ﹤0.01% 3594
2026
Q1 		$303K Buy
23,899
+10,409
+77% +$118K ﹤0.01% 3176
2025
Q4 		$110K Buy
+13,490
New +$155K ﹤0.01% 3479

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Stifel Financial's ORIC Position: Q2 2026 in Review

Stifel Financial reduced its Oric Pharmaceuticals (ORIC) stake by 53% in Q2 2026, selling an estimated $115K and leaving 11,234 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

Stifel Financial first reported a position in ORIC in Q4 2025 and has held it in 3 quarters since. The position peaked at $303K in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Stifel Financial held 11,234 shares of Oric Pharmaceuticals worth $122K as of Q2 2026.
  • Stifel Financial sold 12,665 Oric Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Oric Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3594 holding.
  • Stifel Financial first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Stifel Financial's Oric Pharmaceuticals position peaked at $303K in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.